These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8996613)

  • 1. Appendix. II: Alignment of primary sequences of DNA topoisomerases.
    Caron PR; Wang JC
    Adv Pharmacol; 1994; 29B():271-97. PubMed ID: 8996613
    [No Abstract]   [Full Text] [Related]  

  • 2. Toprim--a conserved catalytic domain in type IA and II topoisomerases, DnaG-type primases, OLD family nucleases and RecR proteins.
    Aravind L; Leipe DD; Koonin EV
    Nucleic Acids Res; 1998 Sep; 26(18):4205-13. PubMed ID: 9722641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzymes that cleave and religate DNA at high temperature: the same story with different actors.
    Serre MC; Duguet M
    Prog Nucleic Acid Res Mol Biol; 2003; 74():37-81. PubMed ID: 14510073
    [No Abstract]   [Full Text] [Related]  

  • 4. A two-subunit type I DNA topoisomerase (reverse gyrase) from an extreme hyperthermophile.
    Krah R; Kozyavkin SA; Slesarev AI; Gellert M
    Proc Natl Acad Sci U S A; 1996 Jan; 93(1):106-10. PubMed ID: 8552584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Appendix. I: An introduction to DNA supercoiling and DNA topoisomerase-catalyzed linking number changes of supercoiled DNA.
    Wang JC
    Adv Pharmacol; 1994; 29B():257-70. PubMed ID: 8996612
    [No Abstract]   [Full Text] [Related]  

  • 6. A topA intein in Pyrococcus furiosus and its relatedness to the r-gyr intein of Methanococcus jannaschii.
    Chute IC; Hu Z; Liu XQ
    Gene; 1998 Mar; 210(1):85-92. PubMed ID: 9524230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of DNA topoisomerases.
    Berger JM
    Biochim Biophys Acta; 1998 Oct; 1400(1-3):3-18. PubMed ID: 9748476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type IA topoisomerases: a simple puzzle?
    Viard T; de la Tour CB
    Biochimie; 2007 Apr; 89(4):456-67. PubMed ID: 17141394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compendium of DNA topoisomerase sequences.
    Caron PR
    Methods Mol Biol; 1999; 94():279-316. PubMed ID: 12844883
    [No Abstract]   [Full Text] [Related]  

  • 10. Attenuating effect of gossypol on tumor growth in systemic malignancies.
    Kapoor S
    Cell Biochem Biophys; 2013; 67(3):1551-2. PubMed ID: 23743711
    [No Abstract]   [Full Text] [Related]  

  • 11. Structure and mechanism of DNA topoisomerases.
    Wigley DB
    Annu Rev Biophys Biomol Struct; 1995; 24():185-208. PubMed ID: 7663114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Similarity in the catalysis of DNA breakage and rejoining by type IA and IIA DNA topoisomerases.
    Liu Q; Wang JC
    Proc Natl Acad Sci U S A; 1999 Feb; 96(3):881-6. PubMed ID: 9927662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gossypol interferes with both type I and type II topoisomerase activities without generating strand breaks.
    Senarisoy M; Canturk P; Zencir S; Baran Y; Topcu Z
    Cell Biochem Biophys; 2013 May; 66(1):199-204. PubMed ID: 23161103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eukaryotic DNA topoisomerase II beta.
    Austin CA; Marsh KL
    Bioessays; 1998 Mar; 20(3):215-26. PubMed ID: 9631649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insights into DNA-binding by type IIA topoisomerases.
    Chang CC; Wang YR; Chen SF; Wu CC; Chan NL
    Curr Opin Struct Biol; 2013 Feb; 23(1):125-33. PubMed ID: 23265999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inhibitors of DNA topoisomerases].
    Andoh T
    Gan To Kagaku Ryoho; 1997 Sep; 24(11):1526-35. PubMed ID: 9309151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Escherichia coli DNA topoisomerase I mutant has a compensatory mutation that alters two residues between functional domains of the DNA gyrase A protein.
    Oram M; Fisher LM
    J Bacteriol; 1992 Jun; 174(12):4175-8. PubMed ID: 1317847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding topoisomerase I and II in terms of QSAR.
    Verma RP
    Bioorg Med Chem; 2005 Feb; 13(4):1059-67. PubMed ID: 15670914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Major groove binding and 'DNA-induced' fit in the intercalation of a derivative of the mixed topoisomerase I/II poison N-(2-(dimethylamino)ethyl)acridine-4-carboxamide (DACA) into DNA: X-ray structure complexed to d(CG(5-BrU)ACG)2 at 1.3-A resolution.
    Todd AK; Adams A; Thorpe JH; Denny WA; Wakelin LP; Cardin CJ
    J Med Chem; 1999 Feb; 42(4):536-40. PubMed ID: 10052960
    [No Abstract]   [Full Text] [Related]  

  • 20. Drugs acting on DNA topoisomerases: recent advances and future perspectives.
    Gatto B; Capranico G; Palumbo M
    Curr Pharm Des; 1999 Mar; 5(3):195-215. PubMed ID: 10066890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.